JPRN-jRCT2080221724未知1 期
Phase I Clinical Trial of DS-7423 - Evaluation of Safety and Pharmacokinetics of DS-7423 in Japanese Patients With Advanced Solid Tumors
DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 27 人开始时间: 2012年2月29日最近更新:
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •Histologically or cytologically diagnosed advanced solid tumors which are not curable with, or not eligible for standard treatment(s)
- •- ECOG performance status: 0-1
排除标准
- •- History of any of the following events within 6 months prior to start of study treatment
- •myocardial infraction, severe/unstable angina pectoris, coronary/peripheral artery bypass graft, congestive heart failure, cerebrovascular accident or cerebral infraction, pulmonary embolism, deep vein thrombosis, or other clinically significant thromboembolic event, clinically significant pulmonary disease (eg severe COPD or asthma)
- •- History of type I and II diabetes
- •- Patient with a clinically active brain metastasis, or who need drugs to control adverse event
- •- History of pneumonitis
- •- Patients with any severe or uncontrolled intercurrent diseases
研究者
相似试验
未知
2 期
DD-723 Phase II clinical trial (Breast)Patients with breast tumorJPRN-jRCT2080220863DAIICHISANKYO Co.,Ltd.75
未知
2 期
DD-723 Phase II clinical trial (Prostate)Patients with suspected prostate cancerJPRN-jRCT2080220862DAIICHISANKYO Co.,Ltd.75
未知
3 期
DD-723 Phase III Clinical Trial (Prostate)Subjects with suspected prostate cancerJPRN-jRCT2080221271DAIICHISANKYO Co.,Ltd.120
未知
3 期
DD-723 Phase III Clinical Trial (Breast)JPRN-jRCT2080221250DAIICHISANKYO Co.,Ltd.120
招募中
1 期
[M23-385]A Phase 1 study of ABBV-706 alone or in combination in adult subjects with advanced solid tumors.Advanced solid tumors with potential SEZ6 expressionJPRN-jRCT2031230510Yamagishi Chika350